Liming Sun

Title: Liming Sun: Innovator in Necrosis Inhibition

Introduction

Liming Sun is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of necrosis inhibitors. With a total of 2 patents, his work focuses on innovative solutions to improve health outcomes.

Latest Patents

Liming Sun's latest patents revolve around necrosis inhibitors. The invention provides amides that inhibit cellular necrosis and/or human receptor interacting protein 1 kinase (RIP1). This includes corresponding sulfonamides, as well as pharmaceutically acceptable salts, hydrates, and stereoisomers thereof. The compounds are utilized in pharmaceutical compositions and methods of making and using them. This includes treating individuals in need with an effective amount of the compound or composition, leading to a detectable improvement in the person's health or condition.

Career Highlights

Liming Sun is affiliated with the National Institute of Biological Sciences in Beijing. His work at this esteemed institution has allowed him to focus on groundbreaking research in the field of cellular health and pharmaceutical applications.

Collaborations

Liming Sun has collaborated with notable colleagues, including Zhiyuan Zhang and Xiaodong Wang. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Liming Sun's innovative work in necrosis inhibitors showcases his dedication to improving health through scientific research. His contributions are significant in the realm of pharmaceuticals, and his patents reflect a commitment to advancing medical science.